3D MEDICINES (01244)
3D Medicines Inc., a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products in the People’s Republic...
- Open
- 2.590
- High
- 2.600
- Low
- 2.465
- Prev. Close
- 2.595
- Volume
- 123.50K
- Turnover
- 317.74K
- Avg Price
- 2.573
- Bid/Ask Ratio
- 37.37%
- Amplitude
- 5.20%
- 52wk High
- 10.020
- Volume Ratio
- 0.61
- Turnover Ratio
- 0.05%
News
- Global Report · Aug 25 at 05:12 AM
Navigating Structural Shifts: Divergent Paths in Hong Kong Equities From Domestic Headwinds to Global Expansion
- Global Report · Aug 25 at 04:20 AM
WH Group Expands as China Rare Earth and Biotechs Chart Uneven Paths
- Market Pulse · Aug 19 at 11:21 PM
Hong Kong Midday: Hang Seng up 1.14%; mRNA stocks explode as Everest Medicines soars 68%
- Tip Ranks · Aug 17 at 11:38 PM
3D Medicines Fully Enforces Arbitration Win Against SELLAS as Key Trial Nears Endpoint
- PUBT · Aug 17 at 08:27 AM
3D Medicines schedules board meeting to review interim results, consider dividend
- Tip Ranks · Aug 7 at 09:39 AM
3D Medicines Revamps Board as Finance Veteran Joins After Non-Executive Director Steps Down
